Dr. Bendell on the Next Steps Following Progression on Immunotherapy in MSI-H CRC
January 4th 2018
Johanna C. Bendell, MD, medical oncologist, Sarah Cannon Research Institute, discusses the next steps following progression on checkpoint inhibitors in microsatellite instability-high (MSI-H) colorectal cancer (CRC).